Related references
Note: Only part of the references are listed.Latency-associated Peptide Identifies Immunoevasive Subtype Gastric Cancer With Poor Prognosis and Inferior Chemotherapeutic Responsiveness
Yifan Cao et al.
ANNALS OF SURGERY (2022)
The evolving role of immune cells in prostate cancer
Chao Wang et al.
CANCER LETTERS (2022)
Androgen receptor activity in T cells limits checkpoint blockade efficacy
Xiangnan Guan et al.
NATURE (2022)
Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer
Hyunwoo Kwon et al.
SCIENCE IMMUNOLOGY (2022)
Human dendritic cells in cancer
Egle Kvedaraite et al.
SCIENCE IMMUNOLOGY (2022)
Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity
Chao Yang et al.
IMMUNITY (2022)
CDK12 Deficiency and the Immune Microenvironment in Prostate Cancer
Tamara L. Lotan et al.
CLINICAL CANCER RESEARCH (2021)
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
Sujun Chen et al.
NATURE CELL BIOLOGY (2021)
CD8+CD103+tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma
Chester Lai et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2021)
Prostate cancer
Richard J. Rebello et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer
Asmaa El-Kenawi et al.
CANCER RESEARCH (2021)
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Emmanuel S. Antonarakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer
Aleksandar Z. Obradovic et al.
CLINICAL CANCER RESEARCH (2020)
Surgical management of high-risk, localized prostate cancer
Lamont J. Wilkins et al.
NATURE REVIEWS UROLOGY (2020)
CD8+ T cell states in human cancer: insights from single-cell analysis
Anne M. Van der Leun et al.
NATURE REVIEWS CANCER (2020)
Tissue-Resident T Cells and Other Resident Leukocytes
David Masopust et al.
Annual Review of Immunology (2019)
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Wenjun Ouyang et al.
IMMUNITY (2019)
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Massimo Locati et al.
Annual Review of Pathology-Mechanisms of Disease (2019)
Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer
Diletta Di Mitri et al.
CELL REPORTS (2019)
Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer
Lorenzo Tosco et al.
EUROPEAN UROLOGY (2019)
PD-L1 Expression and CD8+ T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate Cancer
Florent Petitprez et al.
EUROPEAN UROLOGY FOCUS (2019)
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy
R. Jeffrey Karnes et al.
CLINICAL CANCER RESEARCH (2018)
Interleukin-10 Directly Inhibits CD8+ T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity
Logan K. Smith et al.
IMMUNITY (2018)
Resident memory T cells, critical components in tumor immunology
Fathia Mami-Chouaib et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response
Ayesha A. Shafi et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-Ll expression on tumor-associated macrophages
Canhua Jiang et al.
IMMUNOBIOLOGY (2017)
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy
Shuang G. Zhao et al.
JAMA ONCOLOGY (2017)
LAG-3+tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+tumors
S. Burugu et al.
ANNALS OF ONCOLOGY (2017)
Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer
Anusha-Preethi Ganesan et al.
NATURE IMMUNOLOGY (2017)
Targeting latency-associated peptide promotes antitumor immunity
Galina Gabriely et al.
SCIENCE IMMUNOLOGY (2017)
CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
Bruno G. Leclerc et al.
CLINICAL CANCER RESEARCH (2016)
The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer
Heidrun Gevensleben et al.
CLINICAL CANCER RESEARCH (2016)
TGFβ Signaling Intersects with CD103 Integrin Signaling to Promote T-Lymphocyte Accumulation and Antitumor Activity in the Lung Tumor Microenvironment
Marie Boutet et al.
CANCER RESEARCH (2016)
CD103 and Intratumoral Immune Response in Breast Cancer
Zhi-Qiang Wang et al.
CLINICAL CANCER RESEARCH (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy
Rui Chen et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml1
Rui Chen et al.
ASIAN JOURNAL OF ANDROLOGY (2015)
CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder
Bo Wang et al.
JOURNAL OF UROLOGY (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer
John R. Webb et al.
CANCER IMMUNOLOGY RESEARCH (2015)
TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma
Yijie Chen et al.
BIOLOGICAL RESEARCH (2015)
Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer
John R. Webb et al.
CLINICAL CANCER RESEARCH (2014)
Smad and NFAT Pathways Cooperate To Induce CD103 Expression in Human CD8 T Lymphocytes
M'Barka Mokrani et al.
JOURNAL OF IMMUNOLOGY (2014)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Dual Roles of PARP-1 Promote Cancer Growth and Progression
Matthew J. Schiewer et al.
CANCER DISCOVERY (2012)
Long-Term Survival After Radical Prostatectomy Versus External-Beam Radiotherapy for Patients With High-Risk Prostate Cancer
Stephen A. Boorjian et al.
CANCER (2011)
Minimal Engagement of CD103 on Cytotoxic T Lymphocytes with an E-Cadherin-Fc Molecule Triggers Lytic Granule Polarization via a Phospholipase Cγ-Dependent Pathway
Audrey Le Floc'h et al.
CANCER RESEARCH (2011)
Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancer
Sowmyalakshmi Srinivasan et al.
APOPTOSIS (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
Intracellular signalling controlling integrin activation in lymphocytes
T Kinashi
NATURE REVIEWS IMMUNOLOGY (2005)
Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer
LK Mell et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
